Searchlight Pharma Announces Suvexx® Launch in Europe, along with Deal Expansion to all E.U. Markets
- EUR600K upfront payment upon signing the new amendment agreement - - EUR400K payment once launched in significant...
Read More- EUR600K upfront payment upon signing the new amendment agreement - - EUR400K payment once launched in significant...
Read More• Mithra to receive up to €17.05 million in licensing fees and regulatory and sales milestones, along with...
Read More• Sol-Gel to receive up to $11 million in upfront payments and regulatory and sales milestones for both drugs,...
Read More